• About
  • Policies
  • What is openaccess
  • Library
  • Contact
Advanced search
      View Item 
      •   BUIR Home
      • University Library
      • Bilkent Theses
      • Theses - Department of Molecular Biology and Genetics
      • Dept. of Molecular Biology and Genetics - Master's degree
      • View Item
      •   BUIR Home
      • University Library
      • Bilkent Theses
      • Theses - Department of Molecular Biology and Genetics
      • Dept. of Molecular Biology and Genetics - Master's degree
      • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Investigation of novel tumor markers based on hybridoma technology

      Thumbnail
      View / Download
      974.5 Kb
      Author
      Çelikkaya, Hilal
      Advisor
      Yağcı, Tamer
      Date
      2004
      Publisher
      Bilkent University
      Language
      English
      Type
      Thesis
      Item Usage Stats
      72
      views
      27
      downloads
      Abstract
      Hybridoma technology is a highly specific technique utilized for the production of monoclonal antibodies. In cancer research, monoclonal antibodies are used as tumor markers for diagnosis of malignant tissue versus benign or normal, for differential diagnosis of tumor type, for pathological grading of tumor biopsy specimens, for detection of the antigens that are up- or down-regulated in tumor cells or in sera of cancer patients, and for detection of primary or metastatic lesions. Additionally, monoclonal antibodies are employed in predicting the course of the disease, in diagnostic approaches for carrying imaging reagents to tumors, and in therapy for targeting cytotoxic reagents to and triggering or blocking cell surface molecules. This study involved generation of 6D5 and 9C11 monoclonal antibodies against apoptosis induced hepatocellular carcinoma cell line HuH-7, followed by characterization experiments. 6D5 antibody recognized 5 different epitopes in a panel of 28 cell lines in Western blotting experiments. In immunohistochemistry studies, 6D5 demonstrated positive staining in cirrhotic and cancerous cells of liver cancer tissue samples. On the other hand, 9C11 antibody recognized a single band in the same panel of 28 cell lines but it was not immunoreactive in immunoperixodase studies of liver cancer tissue samples, under our experimental conditions.
      Permalink
      http://hdl.handle.net/11693/29517
      Collections
      • Dept. of Molecular Biology and Genetics - Master's degree 135
      Show full item record

      Browse

      All of BUIRCommunities & CollectionsTitlesAuthorsAdvisorsBy Issue DateKeywordsTypeDepartmentsThis CollectionTitlesAuthorsAdvisorsBy Issue DateKeywordsTypeDepartments

      My Account

      Login

      Statistics

      View Usage StatisticsView Google Analytics Statistics

      Bilkent University

      If you have trouble accessing this page and need to request an alternate format, contact the site administrator. Phone: (312) 290 1771
      Copyright © Bilkent University - Library IT

      Contact Us | Send Feedback | Off-Campus Access | Admin | Privacy